SVT-15652 Otic Solution for the Treatment of Otomycosis

Status Completed

Clinical Trial Summary

Multicenter, randomized, 2-arm parallel-group, double blind, placebo-controlled study in patients suffering from Otomycosis. This study will compare the efficacy and safety of SVT-15652 otic solution to that of Placebo, when administering one vial twice daily during 14 days.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Otomycosis

Clinical Trial Details

NCT number	NCT03686384
Study type	Interventional
Source	Salvat
Contact
Status	Completed
Phase	Phase 3
Start date	February 27, 2020
Completion date	October 25, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01993823` - Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of Otomycosis	Phase 3
Completed	`NCT01547221` - Effectiveness of 3% Boric Acid in 70% Alcohol Versus 1% Clotrimazole Solution in Otomycosis Patients	N/A
Recruiting	`NCT05660382` - Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis	Phase 3
Completed	`NCT03686397` - SVT-15652 Otic Solution for the Treatment of Otomycosis.	Phase 3
Not yet recruiting	`NCT06431542` - Efficacy of Self vs. Physician Application of Triamcinolone-Econazole in Otomycosis	Phase 4
Completed	`NCT06339294` - Efficacy of Pyodine Soaked Gelfoam vs Single Topical Application of Clotrimazole in Otomycosis Treatment	Phase 1
Not yet recruiting	`NCT04824261` - Effectiveness of 4% Boric Acid in Distilled Water Versus Clotrimazole Solution in Otomycosis Patients.	N/A
Completed	`NCT04432376` - Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis)	Phase 2/Phase 3
Completed	`NCT04768829` - Antifungal Potential of Moringa Olifera Against Otomycosis	Early Phase 1
Completed	`NCT03130738` - Dose-Ranging Study for Miconazole Oil for Treatment of Otomycosis	Phase 2